![Schiller DEFIGARD Touch 7 Скачать руководство пользователя страница 142](http://html1.mh-extra.com/html/schiller/defigard-touch-7/defigard-touch-7_user-manual_1212081142.webp)
12
Technical Data
12.4 Technical data - monitoring
Page 142
A
rt.
no.
: 0-48-
0227
Rev.:
g
DEFIGARD/PHYSIOGARD Touch 7
12.4.6
SpO
2
- pulsoximetry
Amplifier
Masimo™
Patent
see web site
www.masimo.com/patents.htm
for detailed patent information
Operation
Normal and sensitive
Measuring range
SpO
2
PP
SpCO
SpMet
PI
0 % to 100 %
25 to 240 /min
0 to 99 %
0 to 99.9 %
0.02 to 20 %
Accuracy
a
SpO
2
(no movement)
SpO
2
(movement)
SpO
2
(low perfusion)
PP (no movement)
PP (movement)
PP (low perfusion)
SpCO
SpMet
• 60 to 80 % ± 3 % adults/children (10 -50 kg)/infants (3-20 kg)
• 70 to 100 % ± 2 adults/children/infants; ± 3 neonates
70 to 100 % ± 3 adults/children/infants/neonates
70 to 100 % ± 2 adults/children/infants/neonates
25 to 240/min ± 3 digits adults/children/infants/neonates
25 to 240/min ± 5 digits adults/children/infants/neonates
25 to 240/min ± 3 digits adults/children/infants/neonates
1 to 40 % ± 3 adults/children/infants
1 to 15 % ± 1 adults/children/infants/neonates
Resolution
SpO
2
PP
SpCO
SpMet
1 %
1 /min
1 %
0.1 %
Calibration range
70 ... 100 %
Connection
Type CF
Displayed range
1 ... 100 %
Blockage caused by defibrillation
shock
Max. 10 seconds
Skin surface temperature
less than 41°C in a minimum 35°C environment